🔓 Unlock the full profile of Cedric Francois (Apellis Pharmaceuticals), including verified contact details, financial insights, and professional associations.
See Cedric Francois Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: ced*****@ape******.com
Mobile: 80164*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Cedric Francois is the Co-Founder and CEO of Apellis Pharmaceuticals, an organization founded in 2008, specializing in innovative therapeutic solutions.
- Under Cedric Francois's leadership, Apellis has successfully developed treatments for various diseases, focusing on complement inhibition to tackle conditions like geographic atrophy and other eye disorders.
- Apellis Pharmaceuticals achieved a significant milestone by becoming a publicly traded company on NASDAQ under the symbol "APLS," reflecting the organization's growth and commercial potential.
- The organization has witnessed a notable market capitalization of approximately $2.2 billion, highlighting its standing in the biotechnology industry.
- Cedric Francois also serves as a Director for the Biotechnology Innovation Organization and the Louisville Healthcare CEO Council, contributing insights on healthcare innovation and industry trends.
- As Co-Founder and Director of Liberate Medical, LLC, Cedric Francois focuses on advancing medical technology aimed at enhancing patient care and outcomes.
- In academia, Cedric Francois holds a position as an Adjunct Professor at the University of Louisville, sharing knowledge and expertise with the next generation of healthcare professionals.
- Despite challenges in the competitive biotechnology landscape, Apellis has maintained a steady pace of growth, with a headcount increase of over 3% in the past year.